Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.68 |
| ▸ | BACE1 | P56817 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | PPARG | P37231 | 2/20 | 0.46 |
| ▸ | FPR2 | P25090 | 2/20 | 0.46 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.46 |
| ▸ | RELA | Q04206 | 1/20 | 0.46 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.45 |
| ▸ | CMKLR1 | Q99788 | 1/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.42 |
| ▸ | GAPDH | P04406 | 1/20 | 0.42 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.41 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15529676 | 1.00 | ACHE (0.68) | ACHEBACE1MAPTALDH1A1PPARG | |
| SCHEMBL15048747 | 0.87 | ACHE (0.84) | ACHEBACE1MAPTALDH1A1PPARG | |
| SCHEMBL1141420 | 0.87 | ACHE (0.84) | ACHEBACE1MAPTALDH1A1PPARG | |
| SCHEMBL3089267 | 0.87 | ACHE (0.84) | ACHEBACE1MAPTALDH1A1PPARG | |
| SCHEMBL3969741 | 0.87 | ACHE (0.84) | ACHEBACE1MAPTALDH1A1PPARG | |
| SCHEMBL25330257 | 0.87 | ACHE (0.84) | ACHEBACE1MAPTALDH1A1PPARG | |
| SCHEMBL1141419 | 0.87 | ACHE (0.84) | ACHEBACE1MAPTALDH1A1PPARG | |
| SCHEMBL3089270 | 0.87 | ACHE (0.84) | ACHEBACE1MAPTALDH1A1PPARG | |
| SCHEMBL31091251 | 0.87 | ACHE (0.84) | ACHEBACE1MAPTALDH1A1PPARG | |
| SCHEMBL1374447 | 0.87 | ACHE (0.84) | ACHEBACE1MAPTALDH1A1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023146984-A1 | LYMPH-RELEASING COMPOSITIONS OF FATTY ACIDS AND USES THEREOF FOR LYMPHATIC INCORPORATION AND SYSTEMIC DISEASE TREATMENT | AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) | 2023-08-03 | — | — | WO | claimed |
| US-20240165066-A1 | LYMPH-RELEASING COMPOSITIONS OF FATTY ACIDS AND USES THEREOF FOR LYMPHATIC INCORPORATION AND SYSTEMIC DISEASE TREATMENT | AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) | 2024-05-23 | — | — | US | disclosed |
| US-11865096-B2 | Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors | SOLUTEX NA LLC | 2024-01-09 | — | — | US | disclosed |
| EP-2858496-B9 | OILS WITH ANTI-INFLAMMATORY ACTIVITY CONTAINING NATURAL SPECIALIZED PRORESOLVING MEDIATORS AND THEIR PRECURSORS | SOLUTEX NA LLC (US) | 2023-11-29 | — | — | EP | disclosed |
| WO-2023146984-A1 | LYMPH-RELEASING COMPOSITIONS OF FATTY ACIDS AND USES THEREOF FOR LYMPHATIC INCORPORATION AND SYSTEMIC DISEASE TREATMENT | AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) | 2023-08-03 | — | — | WO | disclosed |
| EP-4205546-A1 | OILS WITH ANTI-INFLAMMATORY ACTIVITY CONTAINING NATURAL SPECIALIZED PRORESOLVING MEDIATORS AND THEIR PRECURSORS | Solutex NA LLC (US) | 2023-07-05 | — | — | EP | disclosed |
| CN-116173001-A | Oil with anti-inflammatory activity containing natural special pro-resolution medium and its precursor | 索卢泰克斯NA有限责任公司 | 2023-05-30 | — | — | CN | disclosed |
| EP-2858496-B1 | OILS WITH ANTI-INFLAMMATORY ACTIVITY CONTAINING NATURAL SPECIALIZED PRORESOLVING MEDIATORS AND THEIR PRECURSORS | SOLUTEX NA LLC (US) | 2023-04-12 | — | — | EP | disclosed |
| US-20220175711-A1 | OILS WITH ANTI-INFLAMMATORY ACTIVITY CONTAINING NATURAL SPECIALIZED PRORESOLVING MEDIATORS AND THEIR PRECURSORS | SOLUTEX NA LLC | 2022-06-09 | — | — | US | disclosed |
| US-11285126-B2 | Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors | SOLUTEX NA LLC (US) | 2022-03-29 | — | — | US | disclosed |
| US-11077084-B2 | Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors | SOLUTEX NA LLC (US) | 2021-08-03 | — | — | US | disclosed |
| US-20210154163-A1 | OILS WITH ANTI-INFLAMMATORY ACTIVITY CONTAINING NATURAL SPECIALIZED PRORESOLVING MEDIATORS AND THEIR PRECURSORS | SOLUTEX NA LLC | 2021-05-27 | — | — | US | disclosed |
| US-20200281883-A1 | OILS WITH ANTI-INFLAMMATORY ACTIVITY CONTAINING NATURAL SPECIALIZED PRORESOLVING MEDIATORS AND THEIR PRECURSORS | SOLUTEX NA LLC | 2020-09-10 | — | — | US | disclosed |
| US-10568858-B2 | Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors | SOLUTEX NA LLC (US) | 2020-02-25 | — | — | US | disclosed |
| CN-110478342-A | Contain the natural special oil with anti-inflammatory activity for promoting recession medium and its precursor | SOLUTEX NA LLC | 2019-11-22 | — | — | CN | disclosed |
| US-20190201363-A1 | OILS WITH ANTI-INFLAMMATORY ACTIVITY CONTAINING NATURAL SPECIALIZED PRORESOLVING MEDIATORS AND THEIR PRECURSORS | SOLUTEX NA LLC | 2019-07-04 | — | — | US | disclosed |
| US-20180271818-A1 | OILS WITH ANTI-INFLAMMATORY ACTIVITY CONTAINING NATURAL SPECIALIZED PRORESOLVING MEDIATORS AND THEIR PRECURSORS | SOLUTEX NA LLC (US) | 2018-09-27 | — | — | US | disclosed |
| US-20150126602-A1 | OILS WITH ANTI-INFLAMMATORY ACTIVITY CONTAINING NATURAL SPECIALIZED PRORESOLVING MEDIATORS AND THEIR PRECURSORS | SOLUTEX NA LLC | 2015-05-07 | — | — | US | disclosed |
| EP-2858496-A2 | OILS WITH ANTI-INFLAMMATORY ACTIVITY CONTAINING NATURAL SPECIALIZED PRORESOLVING MEDIATORS AND THEIR PRECURSORS | Solutex NA LLC (US) | 2015-04-15 | — | — | EP | disclosed |
| WO-2013170006-A2 | OILS WITH ANTI-INFLAMMATORY ACTIVITY CONTAINING NATURAL SPECIALIZED PRORESOLVING MEDIATORS AND THEIR PRECURSORS | SOLUTEX NA LLC (US) | 2013-11-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240165066-A1 | LYMPH-RELEASING COMPOSITIONS OF FATTY ACIDS AND USES THEREOF FOR LYMPHATIC INCORPORATION AND SYSTEMIC DISEASE TREATMENT | LTA, ALOX5, LIPG | ACHE 381/4885BACE1 3845/4885MAPT 4792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.